Dr. Jennifer Schwenk, MD

Dr. Schwenk practices at Bon Secours St. Mary's Hospital in Richmond, Virginia, part of Bon Secours Mercy Health.

Dr. Schwenk's NPI, 1346635182, was assigned on March 30, 2015. Dr. Schwenk holds Virginia license 0101263902.

Dr. Schwenk's primary practice is Bon Secours St. Mary's Hospital, at 5801 Bremo Rd, Richmond, VA 23226 in Richmond City. The practice phone is (804) 285-2011.

Dr. Schwenk's primary practice is Bon Secours St. Mary's Hospital in Richmond, Virginia, part of Bon Secours Mercy Health. Dr. Schwenk is also affiliated with VCU Medical Center. The medical group on file is CORA Physical Therapy Midlothian. Dmand AI also links Dr. Schwenk to 4 more hospitals, 2 group practices and clinics, 2 home health agencies and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schwenk practices, 10 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Schwenk's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Schwenk is licensed in Virginia.

CMS data shows 1,140 Medicare services from Dr. Schwenk across 5 procedure codes in 2024, for 428 Medicare patients. Medicare paid $44,110 for them. Every service was in an office.

CMS counts 428 Medicare patients who saw Dr. Schwenk in 2024. The largest group is 65 to 74, with 182 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schwenk's median patient age at 70, with 67% women.

In 2024, Dr. Schwenk wrote 5,384 Medicare Part D claims for 535 patients. 90% of them were for generic drugs. CMS names the drug for 4,792 of them, across 95 drugs with 11 or more claims each, at $252,648 in total drug cost. In 2023, CMS named 3,907 claims across 83 drugs.

Dr. Schwenk accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schwenk as offering telehealth.

CMS Open Payments shows 92 general payments to Dr. Schwenk from 24 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 99% of the total. Novo Nordisk Inc paid the most, $247.